Full Service Drug Discovery Contract Research Organization (CRO)
Confluence Discovery Technologies, Inc. (CDT), a wholly owned subsidiary of Aclaris Therapeutics, Inc., serves as research partners for pharma and biotech companies in cell and molecular biology, biochemistry, enzymology, biomarker development, immunology, in vivo efficacy models and medicinal chemistry. We specialize in drug discovery research on complex biological systems, challenging drug targets, immuno-oncology and preclinical and clinical biomarker development.
- Full Service -
Idea to IND
Access our experienced scientists and drug discovery leaders to expedite your project.
- Tailored -
Reach your goal with custom designed research by our experienced experts.
- Plug & Play -
Select solutions from our unique multi‑platform assay options.
Experience & Expertise =
"I've been very impressed with the enzymology and biochemical work that the Confluence team has provided."
—Director Biochemistry and Molecular Pharmacology, Cambridge Mass Biotech
"Thanks for the high-quality science you've offered in our collaborations. We look forward to continue working with you."
—Vice President Biochemical and Cellular Pharmacology, San Francisco Biotech
"I want to say "Thanks" to the Confluence team for your support of both our clinical and preclinical studies."
—Head of Pharmacology, MidWest Biotech
"Your team is great to work with."
—Preclinical Research and Early Development, Cambridge Mass Biotech
"Everything is going great on the Confluence collaborations. We definitely want to continue to work with your team."
—Director Biochemical and Cellular Pharmacology, San Francisco Biotech